Recommended Dosage: Clindamycin 300 mg Twice Daily with Rifampin 300 mg Twice Daily
For adults with hidradenitis suppurativa unresponsive to tetracyclines, the recommended regimen is oral clindamycin 300 mg twice daily combined with rifampin 300 mg twice daily for 10-12 weeks. 1
Dosing Algorithm
Standard Adult Dosing
- Clindamycin: 300 mg orally twice daily (total 600 mg/day)
- Rifampin: 300 mg orally twice daily (total 600 mg/day)
- Duration: 10-12 weeks 1
This represents the most strongly recommended antibiotic combination therapy in the 2019 British Association of Dermatologists guidelines with a strong recommendation rating (↑↑), specifically for patients who have failed oral tetracycline therapy 1.
Alternative Dosing Considerations
Some evidence supports a modified regimen:
- Clindamycin: 600 mg twice daily (total 1200 mg/day)
- Rifampin: 600 mg once daily (total 600 mg/day)
- Duration: 10-12 weeks 2
However, the 300 mg twice daily dosing for both medications remains the guideline-endorsed standard 1.
Clinical Implementation Strategy
Initiation Protocol
Consider starting rifampin alone at 300 mg twice daily for the first 7 days, then adding clindamycin 300 mg twice daily 3. This staged approach may improve tolerability, though it is not universally required.
Treatment Response Assessment
- Evaluate clinical response at 10 weeks using validated measures (HiSCR, IHS4, pain VAS)
- If improvement continues without side effects, treatment may be extended beyond 10-12 weeks 4, 5
- Approximately 73-80% of patients show clinical response with this regimen 4, 6
Important Clinical Considerations
Drug Interactions
Critical caveat: Rifampin is a strong CYP3A4 inducer that significantly reduces clindamycin plasma concentrations 7. However, this combination remains effective for HS, likely due to rifampin's independent anti-inflammatory and anti-biofilm properties beyond simple antimicrobial effects 5, 8.
Monitoring Requirements
- Baseline and periodic liver function tests (both drugs can cause hepatotoxicity)
- Monitor for gastrointestinal side effects, particularly diarrhea and Clostridioides difficile infection with clindamycin
- Rifampin provides some protection against C. difficile, enhancing safety of this combination 5
- Approximately 6.9-31% of patients experience adverse events requiring monitoring 4, 6
Administration Timing
- Rifampin should be taken 1 hour before or 2 hours after meals with a full glass of water 9
- Clindamycin can be taken with or without food 7
Efficacy Expectations
The combination demonstrates:
- Clinical response rate: 73-80% at 10-12 weeks 4, 6
- Remission rate: Approximately 50% 5
- Relapse rate: 59% within 1 year (mean 4.2 months post-treatment) 4
- Particular effectiveness: Better response in abscess/draining tunnel-type HS compared to nodular-type disease 10
Comparative Effectiveness
When compared to adalimumab monotherapy, initiating adalimumab with this antibiotic combination shows superior outcomes, particularly for draining tunnels 11. This suggests the combination may serve as both standalone therapy and as adjunctive treatment with biologics.
Pediatric Considerations
For pediatric patients where capsule swallowing is difficult, an extemporaneous suspension can be prepared at 10 mg/mL concentration using appropriate syrups, stable for 4 weeks 9. However, specific pediatric dosing for HS treatment is extrapolated from adult data, as pediatric trials are limited 12.